Building on the strong momentum established at the Vaccine I-VI meetings, our goal is to gather key leaders in the field to discuss progress and technological challenges facing vaccine development and manufacturing for global needs.

The meeting is organized by scientists from academia and industry in an intimate setting, and differentiates itself from commercial conferences by providing very high quality, cutting-edge scientific content. This format is an outstanding opportunity for exchange of ideas among scientists from diverse backgrounds and with a representation from different regions of the world. Many national and international organizations including The Bill and Melinda Gates Foundation as well as the vaccine industry have supported the previous meetings in this series. We will frequently update our website to inform about confirmed speakers, workshops, abstract submission and registration information.

We are developing a strong scientific program, the draft of which will be available shortly. Following the input from our Scientific Committee, we will organize keynote talks and technical sessions around current and upcoming major issues in vaccine technology.

We invite anyone interested in this conference and in the advancement of vaccine technologies to better deliver vaccines where needed to contact one of the co-chairs of the conference.

Conference Chairs:

Amine Kamen, McGill University
Tarit Mukhopadhyay, University College London
Nathalie Garcon, Bioaster
Charles Lutsch, Sanofi Pasteur

Abstract Submission
Detailed session descriptions are available in the Preliminary Program above. Please use these descriptions to pre-select up to two sessions where you believe your work fits best.

Abstracts (one page maximum) that include specific results and conclusions to allow a scientific assessment of the proposed oral presentation are invited. Please prepared your abstract according to this template: docx or doc.

Abstracts must be submitted electronically using the template provided at: https://ssl.linklings.net/conferences/vaccinetechnology/

Oral abstract submission deadline: March 16, 2018
Poster abstract submission deadline: March 30, 2018

Abstracts of all presentations will be made available to conference participants prior to the start of the conference.

Note: Only a limited number of oral presentation slots are available and thus all submissions for oral sessions will be considered for both oral and poster presentation.

Awards will be presented for the overall best poster and for the top three student posters.